Variant report
Variant | nsv947274 |
---|---|
Chromosome Location | chr1:74537777-74546267 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | GATA3 | chr1:74543769-74543951 | SH-SY5Y | brain: | n/a | n/a |
2 | POLR2A | chr1:74542892-74542901 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:74531200..74533536-chr1:74537407..74539060,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LRRIQ3 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77428096 | chr1:74538807-74538808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565908201 | chr1:74538892-74538893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78837849 | chr1:74538915-74538916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184661789 | chr1:74538971-74538972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115481214 | chr1:74538976-74538977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113063785 | chr1:74538978-74538979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562060682 | chr1:74539082-74539083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115810319 | chr1:74539109-74539110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368219639 | chr1:74539110-74539111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12742029 | chr1:74539128-74539129 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs541195884 | chr1:74539162-74539163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188586379 | chr1:74539175-74539176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150618239 | chr1:74539193-74539194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375364121 | chr1:74539194-74539195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76692879 | chr1:74541407-74541408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538641995 | chr1:74541431-74541432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs77907725 | chr1:74541459-74541460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573943940 | chr1:74541499-74541500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79383044 | chr1:74541516-74541517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111440553 | chr1:74541532-74541533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555162602 | chr1:74541534-74541535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200559010 | chr1:74541543-74541544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146775692 | chr1:74541580-74541581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534528430 | chr1:74541619-74541620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139548179 | chr1:74541632-74541633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562755250 | chr1:74541683-74541684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533173155 | chr1:74541727-74541728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548999982 | chr1:74542896-74542897 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs554365326 | chr1:74542901-74542902 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs111233785 | chr1:74543808-74543809 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs186072368 | chr1:74543812-74543813 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs375595741 | chr1:74543814-74543815 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs562633908 | chr1:74543825-74543826 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs574638646 | chr1:74543832-74543833 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs573954286 | chr1:74543868-74543869 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs560483609 | chr1:74543881-74543882 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs527803352 | chr1:74543902-74543903 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs17589679 | chr1:74543916-74543917 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs564697198 | chr1:74543922-74543923 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs371034591 | chr1:74543950-74543951 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:74538800-74539200 | Enhancers | Pancreas | Pancrea |
2 | chr1:74541400-74541800 | Enhancers | Fetal Heart | heart |
3 | chr1:74546200-74546600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr1:74546200-74546600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr1:74546200-74547200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |